Clinical trial
Splint with Ozone Injection for Mild and Moderate Carpal Tunnel: an Electrodiagnostic Study
NCT06649461 is registered in ClinicalTrials.gov with Selcuk University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Splint with Ozone Injection for Mild and Moderate Carpal Tunnel: an Electrodiagnostic Study
- Lead sponsor
- Selcuk University
- Phase
- Not applicable
- Overall status
- Enrolling by invitation
- Start date
- October 15, 2024
- Completion date
- November 5, 2024
- Enrollment
- 34 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
carpal tunnel syndrome (cts)